Home › twoXAR Joins Stanford University In Hunt For Medicines Targeting Rare Diseases
 

Keywords :   


twoXAR Joins Stanford University In Hunt For Medicines Targeting Rare Diseases

2016-05-03 03:04:31| drugdiscoveryonline News Articles

twoXAR, Inc., a company dedicated to improving health through computation, recently announced a collaboration with Joyce Teng, MD, PhD, of the Department of Dermatology at Stanford University to support research focused on the identification of drug candidates targeting rare disorders such as lymphatic malformation and epidermolysis bullosa simplex (EBS)

Tags: university rare diseases hunt

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
14.05SCS Global Services approved to offer Prop 12 certification
14.05Growth Opportunities for Health and Beauty Care Revenue in Grocery Stores
14.05SONGWON Announces 1Q 2024 Financial Results
14.05Tesco chief's pay more than doubles to 10m
14.05Evonik Receives the Trade Excellence Award in Alabama
14.05My emails look ludicrous, says ex-Post Office PR boss
14.05Feedworks USA grows its monogastric team
14.05Polyart to market full range of services under PolyServices brand
More »